ENTRY       D04112                      Drug
NAME        Etravirine (JAN/USAN/INN);
            Intelence (TN)
  ABBR      ETR
PRODUCT     INTELENCE (Janssen Products LP)
  GENERIC   ETRAVIRINE (Amneal Pharmaceuticals NY LLC)
            ETRAVIRINE (Amneal Pharmaceuticals NY LLC)
            ETRAVIRINE (AvKARE)
            ETRAVIRINE (Carnegie Pharmaceuticals LLC)
            ETRAVIRINE (Leading Pharma)
FORMULA     C20H15BrN6O
EXACT_MASS  434.0491
MOL_WEIGHT  435.2767
CLASS       Antiviral
             DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)
             DG03107  Anti-HIV agent
              DG01656  HIV reverse transcriptase inhibitor
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01643  CYP2C9 inhibitor
             DG01933  CYP2C19 inhibitor
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      Therapeutic category: 6250
            ATC code: J05AG04
            Product: D04112<JP/US>
EFFICACY    Antiviral, Reverse transcriptase inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]
INTERACTION CYP inhibition: CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]
            CYP induction: CYP3A4 [HSA:1576]
            Transporter inhibition: ABCB1 [HSA:5243]
STR_MAP     map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AG Non-nucleoside reverse transcriptase inhibitors
                 J05AG04 Etravirine
                  D04112  Etravirine (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
               Etravirine
                D04112  Etravirine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D04112  Etravirine (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)
               D04112  Etravirine
              DG03107  Anti-HIV agent
               DG01656  HIV reverse transcriptase inhibitor
                D04112  Etravirine
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D04112  Etravirine
              DG01639  CYP2C19 substrate
               D04112  Etravirine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D04112  Etravirine
             Metabolizing enzyme inhibitor
              DG01643  CYP2C9 inhibitor
               D04112  Etravirine
              DG01933  CYP2C19 inhibitor
               D04112  Etravirine
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                D04112  Etravirine
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D04112  Etravirine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D04112  Etravirine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D04112  Etravirine (JAN/USAN/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D04112  Etravirine (JAN/USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04112
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04112
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04112
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04112
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04112
             Drug transporters
              D04112
DBLINKS     CAS: 269055-15-4
            PubChem: 47206062
            ChEBI: 63589
            PDB-CCD: 65B
            LigandBox: D04112
ATOM        28
            1   O2a O    26.3574  -14.2326
            2   C8y C    28.2546  -13.5413
            3   N5x N    29.4434  -14.2276
            4   C8y C    30.6574  -13.5268
            5   N5x N    30.6575  -12.1249
            6   C8y C    29.4687  -11.4385
            7   C8y C    28.2547  -12.1394
            8   X   Br   27.0154  -11.4238
            9   N1a N    29.4686  -10.0270
            10  N1b N    31.8902  -14.2386
            11  C8y C    33.0928  -13.5444
            12  C8x C    34.2788  -14.2292
            13  C8x C    35.4928  -13.5284
            14  C8y C    35.4929  -12.1265
            15  C8x C    34.3069  -11.4416
            16  C8x C    33.0929  -12.1425
            17  C3b C    36.7229  -11.4163
            18  N3a N    37.9369  -10.7154
            19  C8y C    24.4602  -13.5409
            20  C8y C    24.4613  -12.1104
            21  C8x C    23.2494  -11.4094
            22  C8y C    22.0364  -12.1085
            23  C8x C    22.0354  -13.5391
            24  C8y C    23.2473  -14.2400
            25  C3b C    20.8354  -11.4138
            26  N3a N    19.6229  -10.7138
            27  C1a C    23.2461  -15.6100
            28  C1a C    25.6507  -11.4246
BOND        30
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     6   7 2
            7     2   7 1
            8     7   8 1
            9     6   9 1
            10    4  10 1
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   11  16 1
            18   14  17 1
            19   17  18 3
            20    1  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   19  24 1
            27   22  25 1
            28   25  26 3
            29   24  27 1
            30   20  28 1
///
